• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一个肿瘤患者报告结局测量(PROMs)档案:意大利 PRO4All 项目。

The development of an archive of patient-reported outcome measures (PROMs) in oncology: The Italian PRO4All project.

机构信息

Center for Research on Health and Social Care Management, SDA Bocconi School of Management, Milan, Italy.

Department of Oncology, University of Turin, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy; Italian Association of Medical Oncology (AIOM), Italy.

出版信息

Eur J Cancer. 2024 Aug;207:114161. doi: 10.1016/j.ejca.2024.114161. Epub 2024 Jun 10.

DOI:10.1016/j.ejca.2024.114161
PMID:38870746
Abstract

BACKGROUND

Choosing the most adequate measure of patient-reported outcomes (PROs) for a specific medical condition is not straightforward. This study aimed to develop a comprehensive archive of patient-reported outcome measures (PROMs), observer-reported outcome measures (ObsROMs) and caregiver-reported outcome measures (CROMs) in oncology and identify their main characteristics and target outcome domains.

MATERIALS AND METHODS

As part of the Italian PRO4All Project, we retrieved questionnaires through an extensive search of online databases. We developed a data extraction form to collect information on cancer type, questionnaire variant(s), recall period, and scoring system. We performed a content analysis of the questionnaires to assign each item a specific outcome domain according to a predefined 38-item taxonomy.

RESULTS

A total of 386 PROMs (n = 356), ObsROMs (n = 13) and CROMs (n = 17) were identified and described; of these, 358 were also analyzed in their content. 47.3 % of the instruments were cancer type-specific, 45.1 % were generic for cancer and 7.9 % were developed for the general population but also recommended in oncology. The great majority (92.2 %) were patient-reported. In 50.3 % the recall period was "last week". The mean number of items per questionnaire was 22.0 (range: 1-130). 7794 items were assigned an outcome domain, the most frequent being emotional functioning/wellbeing (22 %), physical functioning (15.7 %), general outcomes (10.1 %) and delivery of care (8.9 %).

CONCLUSIONS

There are a variety of patient and caregiver-reported measures in oncology. This archive can guide researchers and practitioners in selecting the most suitable measures and fostering a patient-centered approach in clinical trials, clinical practice, and regulatory activities.

摘要

背景

为特定的医疗状况选择最合适的患者报告结局(PROs)测量方法并非易事。本研究旨在建立一个全面的肿瘤患者报告结局测量(PROM)、观察者报告结局测量(ObsROM)和照顾者报告结局测量(CROM)档案,并确定其主要特征和目标结局领域。

材料和方法

作为意大利 PRO4All 项目的一部分,我们通过广泛搜索在线数据库检索问卷。我们制定了数据提取表格,以收集有关癌症类型、问卷变体、回忆期和评分系统的信息。我们对问卷进行了内容分析,根据预先设定的 38 项分类法,为每个条目分配一个特定的结局领域。

结果

共确定并描述了 386 个 PROM(n=356)、ObsROM(n=13)和 CROM(n=17);其中 358 个也进行了内容分析。47.3%的工具是针对特定癌症类型的,45.1%是通用的癌症工具,7.9%是为一般人群开发的,但也推荐用于肿瘤学。绝大多数(92.2%)是患者报告的。在 50.3%的情况下,回忆期为“上周”。每个问卷的平均条目数为 22.0(范围:1-130)。7794 个条目被分配到一个结局领域,最常见的是情绪功能/幸福感(22%)、身体功能(15.7%)、总体结局(10.1%)和护理提供(8.9%)。

结论

肿瘤学中有多种患者和照顾者报告的测量方法。该档案可以为研究人员和从业者提供指导,帮助他们选择最合适的测量方法,并在临床试验、临床实践和监管活动中促进以患者为中心的方法。

相似文献

1
The development of an archive of patient-reported outcome measures (PROMs) in oncology: The Italian PRO4All project.开发一个肿瘤患者报告结局测量(PROMs)档案:意大利 PRO4All 项目。
Eur J Cancer. 2024 Aug;207:114161. doi: 10.1016/j.ejca.2024.114161. Epub 2024 Jun 10.
2
Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project.用于肿瘤学临床研究和临床实践的患者报告结局测量(PROMs)的乳腺癌特定综合档案:来自 PRO4All 项目的结果。
Breast. 2024 Dec;78:103817. doi: 10.1016/j.breast.2024.103817. Epub 2024 Sep 28.
3
Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review.评价遗传性代谢疾病患者健康相关生活质量的患者报告结局和观察结局指标:范围综述。
Orphanet J Rare Dis. 2018 Nov 28;13(1):215. doi: 10.1186/s13023-018-0953-9.
4
Systematic Review of the Effect of a One-Day Versus Seven-Day Recall Duration on Patient Reported Outcome Measures (PROMs).一天与七天回忆间隔对患者报告结局测量(PROMs)效果的系统评价。
Patient. 2023 May;16(3):201-221. doi: 10.1007/s40271-022-00611-w. Epub 2023 Feb 14.
5
Patient-reported outcome measures for emotional functioning in cancer patients: Content comparison of the EORTC CAT Core, FACT-G, HADS, SF-36, PRO-CTCAE, and PROMIS instruments.癌症患者情绪功能的患者报告结局指标:欧洲癌症研究与治疗组织核心癌症治疗功能评估量表(EORTC CAT Core)、癌症治疗功能评价系统通用量表(FACT-G)、医院焦虑抑郁量表(HADS)、健康调查简表(SF-36)、癌症治疗相关不良事件患者报告结局量表(PRO-CTCAE)及患者报告结果测量信息系统(PROMIS)工具的内容比较
Psychooncology. 2023 Apr;32(4):628-639. doi: 10.1002/pon.6109. Epub 2023 Feb 19.
6
Facets of physical function assessed by patient-reported outcome measures in oncology research.肿瘤学研究中患者报告结局测量评估的身体功能方面。
Qual Life Res. 2024 Jul;33(7):1819-1828. doi: 10.1007/s11136-024-03640-0. Epub 2024 Apr 20.
7
Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review.糖尿病患者的患者报告结局:应该测量什么以及如何测量?一篇叙述性综述。
Diabetologia. 2023 Aug;66(8):1357-1377. doi: 10.1007/s00125-023-05926-3. Epub 2023 May 24.
8
A review of the barriers to using Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs) in routine cancer care.使用患者报告结局(PROs)和患者报告结局测量(PROMs)在常规癌症护理中的障碍综述。
J Med Radiat Sci. 2021 Jun;68(2):186-195. doi: 10.1002/jmrs.421. Epub 2020 Aug 19.
9
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Acne Vulgaris: A Systematic Review of Measure Development and Measurement Properties.患者报告的痤疮患者健康相关生活质量结局测量指标:测量开发和测量特性的系统评价。
JAMA Dermatol. 2022 Aug 1;158(8):900-911. doi: 10.1001/jamadermatol.2022.2260.
10
Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review.评估妇科癌症患者报告结局测量的质量:系统评价。
Future Oncol. 2023 Mar;19(9):663-678. doi: 10.2217/fon-2022-0111. Epub 2023 May 2.

引用本文的文献

1
Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?即将推出的罕见病药物的关键研究:它们是否会比过去更好地支持卫生技术评估和市场准入?
J Mark Access Health Policy. 2025 Jul 25;13(3):37. doi: 10.3390/jmahp13030037. eCollection 2025 Sep.
2
Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM).临床试验和临床实践中的患者报告结局(PROs):来自意大利医学肿瘤学会(AIOM)第21届全国会议的报告
BMJ Oncol. 2025 Jun 17;4(1):e000783. doi: 10.1136/bmjonc-2025-000783. eCollection 2025.
3
Assessing user experience with services: measuring subjective well-being in oncology hospitals.
评估用户对服务的体验:衡量肿瘤医院患者的主观幸福感。
BMC Health Serv Res. 2025 Jun 4;25(1):796. doi: 10.1186/s12913-025-12965-6.
4
Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review.肿瘤临床试验及临床决策中健康相关生活质量测量与生存终点之间的关联:一项叙述性综述
Pharmaceut Med. 2025 May 14. doi: 10.1007/s40290-025-00568-9.
5
Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project.用于肿瘤学临床研究和临床实践的患者报告结局测量(PROMs)的乳腺癌特定综合档案:来自 PRO4All 项目的结果。
Breast. 2024 Dec;78:103817. doi: 10.1016/j.breast.2024.103817. Epub 2024 Sep 28.